by Bruce Sylvester: Patients who have undergone common surgeries are receiving opioid painkillers at an increasing rate, researchers reported on March 18, 2016 in JAMA/Journal of the American… read more.
by Bruce Sylvester: There is no decrease in hospital length of stay among patients hospitalized with acute respiratory failure who have received standardized rehabilitation therapy rather than usual… read more.
by Bruce Sylvester: Following a transient ischemic attack (TIA), quick aspirin treatment can significantly reduce the risk of a major stroke in the next few days, researchers reported… read more.
by Bruce Sylvester: One dosing with methylene blue appears to increase MRI-based response in brain areas that control short-term memory and attention, researchers reported on June 28 in… read more.
by Bruce Sylvester: Women who suffer migraines appear to have an increased risk of heart attacks and strokes as well as a higher rate of mortality from cardiovascular… read more.
by Bruce Sylvester: Pioglitazone shows efficacy against the progression of nonalcoholic steatohepatitis, or NASH, a chronic liver disease caused by a buildup of fat. Researchers reported this finding… read more.
by Bruce Sylvester: Ketamine reduced suicidal thoughts in a small group of patients with treatment-resistant depression, researchers reported on May 10, 2016 in the Journal of Clinical Psychiatry.
by Bruce Sylvester: A single exposure to general anesthesia does not lead to a cognitive risk in healthy children under age three, researchers reported On June 7, 2016… read more.
by Bruce Sylvester: Researchers have identified an across-the-board cardiovascular benefit for patients treated with a diabetes drug, liraglutide, with decreases reported in overall risk of heart attack, stroke,… read more.
by Bruce Sylvester: Researchers from a randomized phase III trial report that addition of temozolomide (Temodar) chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide,… read more.
by Bruce Sylvester: Anti-PD-L1 immunotherapy atezolizumab (TECENTRIQ) has shown efficacy in previously untreated patients with advanced bladder cancer who are ineligible for standard treatment with cisplatin.
by Bruce Sylvester: Investigative rovalpituzumab tesirine (Rova-T) appears to be safe and shows efficacy in treating advanced small cell lung cancer (SCLC), researchers reported in June, 2016 at… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
